Hypoglycemia and Health Costs / 임상당뇨병
Journal of Korean Diabetes
;
: 11-16, 2016.
Artigo
em Coreano
| WPRIM
| ID: wpr-726842
ABSTRACT
Diabetes is one of the most common and rapidly increasing chronic metabolic disorders in the world. It causes serious complications and mortality, with a large burden to the public health care system and to individual patients. Hypoglycemia is an acute complication of diabetes that increases morbidity, mortality, and economic costs. It remains a major limiting factor in the attainment of optimal glycemic control in patients with diabetes. Medical expenditures for potentially preventable severe hypoglycemia are substantial, with the highest proportion of direct medical costs resulting from a relatively small number of patients. Severe hypoglycemia, which is generally associated with insulin or sulfonylurea therapy, can be serious, and hospitalization has been a major driver of increasing healthcare resource use and costs. Patients with increased numbers of non-severe hypoglycemia events are at risk for long-term complications and mortality, reductions in quality of life, increased fear and anxiety, reduced work productivity, and increased healthcare costs. Although the prevalence and incidence of hypoglycemia in diabetes are rapidly increasing in Korea, the economic consequences of hypoglycemia remain unclear.
Texto completo:
DisponíveL
Índice:
WPRIM (Pacífico Ocidental)
Assunto principal:
Ansiedade
/
Qualidade de Vida
/
Saúde Pública
/
Incidência
/
Prevalência
/
Mortalidade
/
Custos de Cuidados de Saúde
/
Gastos em Saúde
/
Atenção à Saúde
/
Diabetes Mellitus
Tipo de estudo:
Avaliação Econômica em Saúde
/
Estudo de incidência
/
Estudo de prevalência
/
Estudo prognóstico
Limite:
Humanos
País/Região como assunto:
Ásia
Idioma:
Coreano
Revista:
Journal of Korean Diabetes
Ano de publicação:
2016
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS